16:33 EDT Applied Therapeutics files to sell 14.29M shares of common stock for holders
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on APLT:
- Largest borrow rate increases among liquid names
- Applied Therapeutics Reveals Strategy and Positive Trial Update
- Applied Therapeutics’ New Accounting & Financial Operations Risk – A Cause for Worry?
- Applied Therapeutics price target raised to $12 from $4 at UBS
- Applied Therapeutics reports FY23 EPS ($1.42), consensus ($1.42)